Product logins

Find logins to all Clarivate products below.


Sports Medicine Devices | Market Insights | Europe (Supplemental) | 2025

This Medtech 360 Report provides high-level market metrics for sports medicine devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe from 2019 through 2033.

Driven by favorable demographic trends, uptake of premium-priced products, and increased availability and quality of surgeon training, the European sports medicine device market will grow at a modest pace through the forecast period through 2033. However, cost controls due to budgetary constraints, limited reimbursement for premium products, and the prevalence of alternative treatments will limit market growth over the forecast period.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period because of rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and increased…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…